Homology Medicines, Inc. (FIXX) Social Stream
HOMOLOGY MEDICINES INC (FIXX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering HOMOLOGY MEDICINES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 6 | $30.001 | $8 | $23 | $0.621 | 3603.7% |
| 2022-01-31 | 6 | $30 | $8 | $22 | $0.621 | 3442.67% |
| 2022-02-22 | 8 | $30 | $8 | $18.2 | $0.621 | 2830.76% |
| 2022-03-25 | 8 | $29 | $8 | $16.2 | $0.621 | 2508.7% |
| 2022-03-30 | 8 | $29 | $4 | $15.4 | $0.621 | 2379.87% |
| 2022-05-16 | 8 | $29 | $4 | $14 | $0.621 | 2154.43% |
| 2022-08-13 | 8 | $29 | $4 | $13.833 | $0.621 | 2127.54% |
| 2022-08-22 | 8 | $20 | $4 | $10.166 | $0.621 | 1537.04% |
| 2022-09-17 | 9 | $20 | $4 | $10 | $0.621 | 1510.31% |
| 2022-11-11 | 9 | $20 | $3 | $9 | $0.621 | 1349.28% |
| 2022-11-17 | 8 | $20 | $3 | $8.75 | $0.621 | 1309.02% |
| 2023-02-08 | 8 | $20 | $3 | $8.75 | $0.621 | 1309.02% |
| 2023-03-12 | 8 | $20 | $2 | $8.375 | $0.621 | 1248.63% |
| 2023-03-16 | 9 | $20 | $2 | $8.375 | $0.621 | 1248.63% |
| 2023-05-15 | 9 | $20 | $2 | $8.571 | $0.621 | 1280.19% |
| 2023-06-06 | 7 | $20 | $2 | $8 | $0.621 | 1188.24% |
| 2023-07-28 | 3 | $6 | $1.5 | $3.5 | $0.621 | 463.61% |
The Trend in the Analyst Price Target
Over the past 49 weeks, FIXX's average price target has gone down $5.79.
FIXX reports an average of 448.16% for its upside potential over the past 26 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-06 | 9 | 20 | 2.0 | 8.428 | 1.04 | 710.38% |
| 2023-06-06 | 9 | 20 | 2.0 | 8.666 | 1.04 | 733.27% |
| 2023-07-28 | 2 | 7 | 1.5 | 4.375 | 1.33 | 228.95% |
| 2023-07-28 | 4 | 6 | 1.5 | 3.125 | 1.33 | 134.96% |
| 2023-07-28 | 2 | 6 | 1.5 | 3.500 | 1.33 | 163.16% |
FIXX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.5 | 1 | 0 | 3 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
FIXX's average broker recommendation rating worsened by 1 over the prior 13 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, HOMOLOGY MEDICINES INC's upside potential (average analyst target price relative to current price) is greater than 2733.55% of them.
- In terms of how HOMOLOGY MEDICINES INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2585.01% of that group.
- In the context of stocks in the small market cap category, HOMOLOGY MEDICINES INC's number of analysts covering the stock is higher than 2104.49% of them.
- HOMOLOGY MEDICINES INC's average analyst price target is greater than 514.72% of Healthcare stocks.
In the Pharmaceutical Products industry, BTAI, IFRX, and MBIO are the three stocks most similar to HOMOLOGY MEDICINES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is FIXX a Buy, Hold or Sell? See the POWR Ratings now!